Mikesh Udani

Mikesh Udani is the current CEO of Albus Health. Prior to this, they were a Oxford Biodesign Fellow at the Institute of Biomedical Engineering, University of Oxford from September 2016 to September 2017. Their focus there was on medical technology innovation with an inclination on digital healthcare. From October 2015 to September 2016, they were a graduate student at the Department of Computer Science at the University of Oxford. Their masters thesis was on decoding hypertrophic cardiomyopathy using machine learning on ionic profiles. Prior to that, they worked as a senior analyst at Deutsche Bank from July 2012 to September 2015 where they were responsible for risk analysis and hedging for fixed income derivatives portfolio as well as developing the portfolio's risk management platform. In May 2011, they were a team leader for a project commissioned by the IARPA (US National Intelligence) at Carnegie Mellon University. The project was an audio diarization system for classification of data. Mikesh also interned at Carnegie Mellon University in May 2010 to July 2010.

Mikesh Udani completed a Master's Degree in Computer Science at the University of Oxford. Prior to that, they completed an Integrated M.Sc. in Mathematics and Computing at the Indian Institute of Technology, Kharagpur. Mikesh also attended La Martiniere School for their high school education.

Richard Russell - Clinical Lead, Maarten De Vos - Head of R&D, and Mona Bafadhel - Clinical Lead report to Mikesh Udani.